Our Gainsborough partnership invests in companies quoted on AIM and Plus markets. The partnership will develop a portfolio of approximately 20 companies. Gainsborough will allocate 20% of its funds to approximately 10 “Earlier Companies” and 80% of its assets to approximately 10 Later Companies. This defensive asset allocation profile will give partners exposure to exciting younger companies, while giving the portfolio a base of more developed companies.
To date the partnership has invested in the following companies:
* Plastics Capital plc (http://www.plasticscapital.com/)
* Surface Transforms plc (http://www.surface-transforms.com/)
* Immunodiagnostic Systems Holdings plc (http://www.idsltd.com)
* BrainJuicer Group plc (www.brainjuicer.com)
* Scancell Holdings plc (www.scancell.co.uk)
| Company | Date | Round | Size | Participants |
| OmniGuide | 5/08 | Series E | $25M | 7 |
